In the case of medicinal products containing active substances used in the composition of authorised medicinal products but not hitherto used in combination for therapeutic purposes, the results of new pre-clinical tests or new clinical trials relating to that combination shall be provided in accordance with Article 8(3)(i), but it shall not be necessary to provide scientific references relating to each individual active substance.
Art. 10b Directive (EU) 2001/83
The 10 that are cited most themselves, of 16.
Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 20…166Law
… 3, artikel 10, 10a, 10b og 11 eller artikel 32, stk. 5, i direktiv 2001/83/EF og bilag I hertil eller i artikel 9, stk. 4, i denne forordning. Navnlig underretter indehaveren af markedsføringstilladelsen straks agenturet og Kommissionen …
Judgment of the Court (Fifth Chamber), 23 October 2014. Olainfarm AS v Latvijas Republikas Veselības ministrija and Zāļu valsts aģentūra.Decision
… 8 odst. 3, články 10a, 10b nebo 10c směrnice 2001/83.
23 Oct 2014 · 62013CJ0104
Regulation (EU) No 1235/2010 of the European Parliament and of the Council of 15 Decembe…1Law
… 3, artikel 10, 10a, 10b og 11 eller artikel 32, stk. 5, i direktiv 2001/83/EF og bilag I hertil eller i artikel 9, stk. 4, i denne forordning. Navnlig underretter indehaveren af markedsføringstilladelsen straks agenturet og Kommissionen …
Judgment of the Court (Second Chamber) of 14 March 2018. Proceedings brought by Astellas Pharma GmbH.Decision
Article 19(1) of Directive 2001/83 provides that, in order to examine the application submitted in accordance with Articles 8, 10, 10a, 10b and 10c, the competent authority of a Member State must verify whether the particulars submitted in …
14 Mar 2018 · 62016CJ0557
Opinion of Advocate General Wahl delivered on 20 May 2014. Olainfarm AS v Latvijas Republikas Veselības ministrija and Zāļu valsts aģentūra.Decision
Existuje však několik výjimek z uvedeného pravidla [Tyto výjimky jsou obsaženy v článcích 10, 10a, 10b, a 10c směrnice 2001/83. V následujících bodech posoudím pouze výjimky stanovené v článcích 10 a 10a, neboť pouze ty …
20 May 2014 · 62013CC0104
Opinion of Advocate General Bobek delivered on 21 December 2016.Decision
The examples provided by the Commission on changes to the initial medicinal product that do not fall within the same GMA all concern scenarios under which there is a change to the active substance (or combination of active substances) in …
21 Dec 2016 · 62015CC0629
Opinion of Advocate General Sharpston delivered on 22 April 2010. European Commission v Republic of Lithuania.Decision
That can be derived from the fact that, in Regulation No 726/2004, recital 14 provides that the quality, safety and efficacy criteria laid down in Directives 2001/82 and 2001/83 are to apply to medicinal products authorised by the …
22 Apr 2010 · 62008CC0350
Opinion of Mr Advocate General Mazák delivered on 26 March 2009. The Queen, on the application of Generics (UK) Ltd v Licensing Authority.Decision
… 8 odst. 3, články 10a, 10b nebo 10c směrnice 2001/83“ [Kapitola 1, oddíl 5.3.1., zvýraznění provedeno autorem tohoto stanoviska.].
26 Mar 2009 · 62007CC0527
Judgment of the General Court (Seventh Chamber, Extended Composition) of 5 May 2021. Pharmaceutical Works Polpharma S.A. v European MedicineDecision
Thus, according to Article 30(1) of Directive 2001/83, if two or more applications submitted in accordance with Articles 8, 10, 10a, 10b, 10c and 11 of that directive have been made for marketing authorisation for a particular medicinal …
5 May 2021 · 62018TJ0611
Judgment of the Court (Grand Chamber) of 23 January 2018. F. Hoffmann-La Roche Ltd and Others v Autorità Garante della Concorrenza e del MerDecision
… 8 odst. 3 a v článcích 10, 10a, 10b a 11 směrnice 2001/83/ES, v její příloze I nebo v čl. 9 odst. 4 tohoto nařízení. Zejména neprodleně informuje [EMA], Komisi a členské státy o každém zákazu nebo omezení uloženém …
23 Jan 2018 · 62016CJ0179
- 26 Jan 2007 – todayin force
- 30 Apr 2004 – 26 Jan 2007earlier wording
Versions are held from 6 Nov 2001; the article may be older.